Cargando…

Targeting MicroRNAs in Prostate Cancer Radiotherapy

Radiotherapy is one of the most important treatment options for localized early-stage or advanced-stage prostate cancer (CaP). Radioresistance (relapse after radiotherapy) is a major challenge for the current radiotherapy. There is great interest in investigating mechanisms of radioresistance and de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ni, Jie, Bucci, Joseph, Chang, Lei, Malouf, David, Graham, Peter, Li, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595129/ https://www.ncbi.nlm.nih.gov/pubmed/28900507 http://dx.doi.org/10.7150/thno.19934

Ejemplares similares

Proteomic identification of the lactate dehydrogenase A in a radioresistant prostate cancer xenograft mouse model for improving radiotherapy
por: Hao, Jingli, et al.
Publicado: (2016)

Extracellular vesicles: the next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis
por: Pang, Bairen, et al.
Publicado: (2020)

MicroRNAs in prostate cancer
por: Kim, Won Tae, et al.
Publicado: (2012)

microRNAs and prostate cancer
por: Shi, Xu-Bao, et al.
Publicado: (2008)

Identification of protein biomarkers and signaling pathways associated with prostate cancer radioresistance using label-free LC-MS/MS proteomic approach
por: Chang, Lei, et al.
Publicado: (2017)

Exosomes in Cancer Radioresistance
por: Ni, Jie, et al.
Publicado: (2019)

Quality Assessment and Comparison of Plasma-Derived Extracellular Vesicles Separated by Three Commercial Kits for Prostate Cancer Diagnosis
por: Pang, Bairen, et al.
Publicado: (2020)

Cancer stem cells and signaling pathways in radioresistance
por: Chang, Lei, et al.
Publicado: (2015)

Diet, MicroRNAs and Prostate Cancer
por: Saini, Sharanjot, et al.
Publicado: (2010)

MicroRNAs Associated with Metastatic Prostate Cancer
por: Watahiki, Akira, et al.
Publicado: (2011)

Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo
por: Ni, Jie, et al.
Publicado: (2018)

MicroRNAs in Prostate Cancer: Implications for Treatment Response and Therapeutic Targets
por: Hussein, Mohamed Ali, et al.
Publicado: (2023)

The role of microRNAs in prostate cancer progression
por: Lo, U-Ging, et al.
Publicado: (2013)

Role of MicroRNAs in Neuroendocrine Prostate Cancer
por: Sreekumar, Amritha, et al.
Publicado: (2022)

Molecular assays for the detection of microRNAs in prostate cancer
por: Siva, Amara C, et al.
Publicado: (2009)

Recent updates on the role of microRNAs in prostate cancer
por: Hassan, Oudai, et al.
Publicado: (2012)

AB003. Urinary microRNAs of prostate cancer
por: Kim, Wun-Jae
Publicado: (2016)

MicroRNAs and epithelial-mesenchymal transition in prostate cancer
por: Sekhon, Kirandeep, et al.
Publicado: (2016)

Role of MicroRNAs in Treatment Response in Prostate Cancer
por: Razdan, Anshuli, et al.
Publicado: (2018)

Human Prostate Tissue MicroRNAs and Their Predicted Target Pathways Linked to Prostate Cancer Risk Factors
por: Enwald, Max, et al.
Publicado: (2021)

MicroRNAs as Epigenetic Determinants of Treatment Response and Potential Therapeutic Targets in Prostate Cancer
por: Doldi, Valentina, et al.
Publicado: (2021)

Identification of microRNAs and their Endonucleolytic Cleavaged target mRNAs in colorectal cancer
por: Zhou, Fangbin, et al.
Publicado: (2020)

Data on microRNAs and microRNA-targeted mRNAs in Xenopus ectoderm
por: Shah, Vrutant V., et al.
Publicado: (2016)

Targeting MicroRNAs in Cancer Gene Therapy
por: Ji, Weidan, et al.
Publicado: (2017)

Therapeutic opportunities for targeting microRNAs in cancer
por: Taylor, Molly A, et al.
Publicado: (2014)

Targeting MicroRNAs for Personalized Cancer Therapy
por: Li, Yiwei, et al.
Publicado: (2013)

MicroRNAs as Molecular Targets for Cancer Therapy: On the Modulation of MicroRNA Expression
por: Costa, Pedro M., et al.
Publicado: (2013)

Circulating MicroRNAs as Biomarkers of Prostate Cancer: The State of Play
por: Sapre, Nikhil, et al.
Publicado: (2013)

Circulating microRNAs as potential new biomarkers for prostate cancer
por: Sita-Lumsden, A, et al.
Publicado: (2013)

Role of microRNAs in the resistance of prostate cancer to docetaxel and paclitaxel
por: Kopczyńska, Ewa
Publicado: (2016)

MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer
por: Bertoli, Gloria, et al.
Publicado: (2016)

Significance of microRNAs in Androgen Signaling and Prostate Cancer Progression
por: Takayama, Ken-ichi, et al.
Publicado: (2017)

MicroRNAs in treatment-induced neuroendocrine differentiation in prostate cancer
por: Akoto, Theresa, et al.
Publicado: (2020)

Identification of MicroRNAs as Viable Aggressiveness Biomarkers for Prostate Cancer
por: Martínez-González, Luis Javier, et al.
Publicado: (2021)

Use of MicroRNAs as biomarkers in the early diagnosis of prostate cancer
por: Canatan, Duran, et al.
Publicado: (2022)

Oligonucleotides and microRNAs Targeting Telomerase Subunits in Cancer Therapy
por: Eckburg, Adam, et al.
Publicado: (2020)

Regulation of MicroRNAs, and the Correlations of MicroRNAs and Their Targeted Genes by Zinc Oxide Nanoparticles in Ovarian Granulosa Cells
por: Zhao, Yong, et al.
Publicado: (2016)

Target RNAs Strike Back on MicroRNAs
por: Fuchs Wightman, Federico, et al.
Publicado: (2018)

MicroRNAs in cancer metastasis and angiogenesis
por: Lou, Weiyang, et al.
Publicado: (2017)

Iodine-125 prostate seed brachytherapy in renal transplant recipients: an analysis of oncological outcomes and toxicity profile
por: Beydoun, Nadine, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rp8m9rbqbhp7prchqgtt1f49gf